Publications

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • Embracing the Next Energy Revolution: Electricity Storage

    October 18, 2017 | Bain Brief

    As battery costs decline, utilities and their customers are beginning to deploy large-scale energy storage.

  • Bain & Co.'s Rafael Natanek on how to make your drug launch a success

    September 27, 2017 | Pharmaceuticals | S&P Global | Media mention

    Following a survey of 100 executives at the top 20 pharmaceutical companies, Rafael Natanek, a partner with Bain & Company, talked to S&P Global Market Intelligence about the critical importance of a successful new drug launch, given that drug companies will derive 25% to 80% of their revenue from

  • Customer Behavior and Loyalty in Insurance: Global Edition 2017

    September 14, 2017 | Bain report

    Insurers have long struggled to attract and retain customers. They do business in a highly competitive marketplace, and they sell a product that many consumers consider to be a commodity.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • European banking landscape increasingly polarized, says analyst

    September 06, 2017 | Banking | CNBC | Media mention

    Strong banks have been getting stronger but a number of banks could be in danger, João Soares, partner with Bain & Company, told CNBC.

  • Battle of the Banks: The Fight for Profitable Business Models in Europe

    September 04, 2017 | Bain Brief

    European banks as a whole are running hard just to stand still. Sure, in light of the higher capital buffers they have erected, the banks might appear to be fairly resilient when viewed through recent stress tests by regulators.

  • Number of European lenders in danger rises sharply

    September 04, 2017 | Banking | Financial Times | Media mention

    A new report by Bain & Company shows that the number of European banks in grave danger rose sharply last year and is now close to its 2013 level, despite extensive efforts by lenders to bolster balance sheets and profits. "The fragile banks that have not acted effectively or that delayed taking

  • The construction industry: Least improved

    August 19, 2017 | Infrastructure, Construction & Building Products | The Economist | Media mention

    Volatility in demand for construction has trained builders to curb investment. "The industry has learned through bitter experience to prepare for the next recession," says Luc Luyten, a partner with Bain & Company.

  • Beyond Kumbaya: Three Steps to Manage Change and Bring People Together After a Merger

    August 07, 2017 | Managing Change Blog

    If you do not invest time and resources in change management, people and cultural issues will eat all your anticipated synergies for breakfast—and your entire company for lunch.